Researchers developed a neoAg mRNA-based vaccine that induces higher frequency of neoAg-specific cytotoxic T cells in mice, leading to tumor regression and eradication. The combination with anti-PD-1 therapy enhances antitumor efficacy, especially against peritoneal metastasis.
A new survey reveals that IBS symptoms continue to significantly impact patients' daily lives and productivity, with disruptions occurring nearly 19 days per month. Patients report missing more work/school days due to their symptoms and spending less time with family and friends.
Research reveals that Faecalibacterium prausnitzii inhibits the growth of Fusobacterium varium, promoting a balance in the gut microbiota. This interaction is likely to occur through direct contact between the bacteria, and may have implications for improving intestinal health.
A global study found that cancer immunotherapies carry a hidden risk: cholestasis, a serious liver condition. Researchers urge aggressive monitoring of liver function, particularly in younger adults and women.
A low FODMAP diet has been shown to improve colonic barrier function and reduce mast cell activation in patients with IBS-D. The study found that the diet reduced symptoms of diarrhea and abdominal pain, and improved intestinal permeability.
The Mount Sinai Hospital has been listed among the nation's top 20 hospitals for care excellence by U.S. News & World Report for 2025-26, with top-10 rankings in five specialties and top-20 rankings in nine. The hospital was also rated High Performing in all 22 procedures and conditions assessed by U.S. News.
Researchers discovered a rare case where two cancer-related mutations coexisted in a woman with FAP and a history of endometrial cancer. This case may reveal new insights into how different genetic mutations can cooperate to promote cancer development.
Research review finds handgrip strength is a reliable predictor of cirrhosis complications and outcomes, including malnutrition, muscle loss, cognitive impairment, hepatic encephalopathy, and mortality. Regular HGS assessments can inform timely personalized interventions to enhance patient quality of life.
A research team at Osaka Metropolitan University has developed an AI model that can detect fatty liver disease from chest X-ray images with an accuracy rate of 0.82-0.83. This breakthrough has the potential to improve early detection and treatment of the disease, which affects one in four people worldwide.
A pilot study found that the Mediterranean diet provided symptom relief for patients with irritable bowel syndrome (IBS), with 73% of participants experiencing improvement. The low FODMAP diet was also effective but led to greater improvements in abdominal pain intensity and IBS severity score.
A review examines the evidence and mechanisms behind GERD-associated eosinophilia and whether GERD alone can meet EoE-level eosinophilic thresholds. High-level esophageal eosinophilia is rare in GERD without concomitant eosinophilic esophagitis.
AGA President Dr. Lawrence Kim is an endoscopy expert and diversity champion who will ensure the society is inclusive for all gastroenterologists. He aims to secure research viability and support next-generation leaders.
Researchers at Stanford University have developed a modular biosensor called SENSBIT that can continuously track drug concentration profiles in real time. The device has remained functional for up to seven days when implanted directly into the blood vessels of live rats.
A retrospective study found that allogeneic hematopoietic stem cell transplant is a highly effective method for treating children with monogenic inflammatory bowel disease, resulting in sustained medication-free remission in over 90% of patients. The treatment also led to significant improvements in growth, reduced hospital visits, and...
Researchers found AI outperformed physicians in answering GI cancer questions, with oncologists preferring ChatGPT's responses nearly 80% of the time. Additionally, fewer patients are getting surgery for benign colon polyps as endoscopic techniques rise, reducing serious complications and mortality rates.
The UCLA Walter and Shirley Wang Center for Integrative Digestive Health will offer comprehensive care, support, and guidance for patients with gastrointestinal disorders. The new center utilizes an integrative health approach to treat GI diseases and improve quality of life.
A phase II trial found that PD-1 blockade with dostarlimab induced complete tumor clearance and resolved the need for surgery in patients with early-stage mismatch repair-deficient cancers. This approach showed promise for preserving organs, improving quality of life, and potentially increasing survival.
A 20-year initiative that offered flexible screening options at a major health system doubled screening rates and cut cancer incidence by a third, halving deaths. The program eliminated racial disparities in outcomes, with Black patients' deaths declining from 52.2 to 23.5 per 100,000.
A study published in Journal of Proteome Research reveals that inflammation and aging contribute to the development of non-viral liver cancer. Researchers analyzed gene expression and metabolites in normal and affected samples, identifying potential therapeutic targets for chemoprevention.
The study directly compared Droplet-based scRNA (D-scRNA) and Picowell-based scRNA (P-scRNA) platforms for analyzing human mucosal biopsies. D-scRNA provides more detailed insights, but requires resources and may introduce contamination. P-scRNA is gentler, more resource-efficient, but less effective in capturing rare cell types.
A study using machine learning models found that people with IBD are at risk for premature death when developing other chronic health conditions earlier in life. Chronic conditions like arthritis, hypertension, and mood disorders were common causes of death among those with IBD.
A new clinical guideline from the American Gastroenterological Association suggests that artificial intelligence-assisted colonoscopy may improve polyp detection rates, but its impact on preventing colorectal cancer remains uncertain. The guideline recommends a cautious approach to widespread adoption, emphasizing the need for further ...
The Asia-Pacific region's H. pylori treatment practices show a growing consensus on primary and secondary prevention, but differences in antimicrobial resistance and medical resources persist. Establishing uniform standards for gastric cancer prevention will be crucial to addressing these disparities.
Patients with severe ischemic stroke show impaired gastric motility and autonomic dysfunction, with reduced normal gastric slow waves and increased sympathetic activity. These findings suggest a link between gastric myoelectrical rhythms and autonomic function in ischemic stroke.
The American Gastroenterological Association has chosen 16 exceptional gastroenterologists and hepatologists for its Future Leaders program. The selected doctors will work on career development projects over 18 months, focusing on the future of the digestive diseases field.
Researchers found that semisynthetic bile acid NorUDCA inhibits pro-inflammatory T helper 17 cells and promotes anti-inflammatory regulatory T cells in the intestine. This could lead to new therapies for inflammatory bowel diseases such as ulcerative colitis or Crohn's disease.
A cross-sectional survey revealed high costs, inadequate training, and poor financing as major challenges to gastrointestinal endoscopy practice in Nigeria. Locally developed innovations have eased the practice, preventing it from collapsing.
Repeated esophagogastroduodenoscopy and colonoscopy enhance lesion detection, particularly in cases with active bleeding or poor visualization. The diagnostic accuracy of these procedures increases patient outcomes.
The updated recommendations from the US Multi-Society Task Force on Colorectal Cancer aim to achieve a benchmark of 90% exams with adequate bowel preparation. The guidelines focus on optimizing bowel preparation before, during, and after colonoscopy, including patient education, dietary restrictions, and choice of preparation agent.
Children who frequently miss school due to abdominal complaints are more likely to have gut-brain axis disorders like IBS, which can be missed by medical tests. The study found that frequent absences were nearly five times more likely to be caused by functional GI disorders than specific illnesses.
A Japanese version of the Esophageal Hypervigilance and Anxiety Scale has been developed and validated for clinical use in Japan. The scale, which evaluates symptom-specific hypervigilance and anxiety for esophageal symptoms, showed validity comparable to standardized mental and physical health surveys.
A long-term study found that Roux-en-Y gastric bypass outperforms sleeve gastrectomy in treating obesity, with patients losing more excess body mass index. The Swiss Multicenter Bypass or Sleeve Study demonstrated the superiority of Roux-en-Y gastric bypass over sleeve gastrectomy for patient weight loss.
A blood test has been found to identify personalized dietary triggers for patients with irritable bowel syndrome, resulting in improved abdominal pain relief. The study showed that 59.6% of participants who removed trigger foods experienced significant reduction in abdominal pain compared to 42.2% in the control group.
A study from Weill Cornell Medicine found that over two-thirds of US counties have no gastroenterologist, leaving millions without access to care. The analysis highlights the need for policy interventions and strategies to expand the workforce in underserved areas.
Jeremy L. Davis, MD, has been appointed as the new Surgical Oncology Lead for UMGCCC and Chief of the Division of Surgical Oncology in the Department of Surgery at UMSOM. Dr. Davis is a nationally recognized surgical oncologist with expertise in gastric cancer research.
A new study from Aarhus University Hospital shows that fecal microbiota transplantation can be a safe and effective treatment for patients with type 1 diabetes and gastroenteropathy. The treatment has significantly improved quality of life and symptoms for participants, offering hope to those with debilitating symptoms.
A study by MedUni Vienna identified a promising therapeutic approach for metabolic liver diseases by targeting fat metabolism inhibition, promoting liver health and reducing liver fat, inflammation and fibrotic remodeling. The approach involves blocking ATGL, an enzyme playing a central role in lipid metabolism.
Researchers discovered a novel combination of plasma-based biomarkers that can predict liver fibrosis in Latino adolescents with obesity. The study found that dihydroxyacetone phosphate (DHAP) and alanine transaminase (ALT) were significantly associated with fibrosis, suggesting a potential low-cost, noninvasive screening tool.
Three Sanford Burnham Prebys faculty members, David A. Brenner, Randal J. Kaufman, and Tariq M. Rana, are recognized for their significant scientific influence. Their publications have been cited top 1% globally by number of citations.
A survey of GI fellows found that gastroenterologists providing inpatient care improve education through enhanced endoscopy teaching and longitudinal feedback. This model is expected to create more robust fellowship programs across the US, combining benefits of both GI Hospitalist and non-GI Hospitalist faculty.
Scientists at UMC Utrecht developed a new technology to isolate and study gut bacteria recognized by IgA antibodies, which are associated with various diseases. The next-generation IgA-SEQ method allows for high-throughput identification and analysis of these immunostimulatory bacteria, shedding light on their role in health and disease.
Researchers found that using a multi-step strategy with less-invasive devices can identify patients with Barrett's oesophagus before an endoscopy. This approach is promising for cost-effective screening, which could lead to earlier diagnosis and treatment of oesophageal cancer.
A new multi-specialty guidance provides clarity on the usage of GLP-1 receptor agonists before elective surgery and gastrointestinal endoscopies. For most patients, these medications can be safely continued, but individual risk factors for complications should be assessed prior to surgery.
Genetic variations in carbohydrate-active enzymes may predict which IBS patients benefit from low-carb diets, offering potential personalized treatment options. A study of 250 IBS patients found that those with defective genes showed marked improvement on a low-FODMAP diet.
A study found that HLA-DRB1*01:03 is associated with severe ulcerative colitis, requiring major operations and systemic corticosteroid use. The allele has previously been linked to ulcerative colitis incidence, supporting earlier genetic studies.
The 2024 Chinese consensus on radiofrequency therapy for gastroesophageal reflux disease standardizes treatment approaches by outlining essential surgical indications, contraindications, and postoperative management. The consensus also highlights the importance of precise energy application to the lower esophagus and cardia.
Advanced endoscopy combined with AI and digital pathology offers a deeper understanding of inflammatory bowel diseases (IBD). This leads to more accurate diagnoses and improved patient outcomes.
The new guideline updates treatment recommendations for Helicobacter pylori infection, shifting away from proton pump inhibitor-clarithromycin triple therapy. Bismuth quadruple therapy and other alternatives are now recommended for treatment-naïve patients.
A survey of 10,000 Japanese adults found that belching disorders are more prevalent in men who drink alcohol and take acid reflux medications. The study also identified factors such as eating until feeling full and low chewing frequency as significant contributors to the development of belching disorders.
The article discusses current endoscopic treatment approaches for IBD-related complications, highlighting the advantages and disadvantages of techniques like EBD and EMR. These methods offer minimally invasive options but require expertise and careful patient selection.
New studies suggest a simplified, less restrictive low FODMAP diet may be effective for managing irritable bowel syndrome (IBS). The alternative 'FODMAP-simple' diet restricts only fructans and galacto-oligosaccharides without restricting other FODMAP groups. This approach may reduce symptoms and improve patient adherence to the diet.
Cyclic vomiting syndrome (CVS) is a disabling condition affecting up to 2% of the population, with most patients experiencing years of diagnostic delays. CVS can be managed through lifestyle modifications and medications, with timely diagnoses crucial to prevent complications.
A large-scale study confirms the rising incidence of eosinophilic esophagitis (EoE) in Japan, with a significant increase in cases between 2005 and 2022. The study found an incidence rate of 2.82 per 100,000 person-years and a prevalence rate of 10.68 per 100,000 people.
A study by Nanyang Technological University found that eight in 10 gastroenterologists in the Asia-Pacific region accept and trust AI-powered tools for diagnosing colorectal polyps. The study also highlights the need for more research into what influences doctors' acceptance of AI in their medical practice.
Researchers at Virginia Tech have discovered a possible new pathway to treat colorectal cancer by targeting the NF-kB-inducing kinase (NIK) protein. The study, led by Irving Coy Allen, identifies changes in a significant signaling pathway in human patients and presents potential targets for therapeutics.
A robotic device mimics natural esophageal and intestinal movement to aid digestion, helping patients with blockages caused by tumors or stents. The device has the potential to improve quality of life for the aging population.
A recent NTU Singapore study found that eight in ten gastroenterologists accept and trust the use of AI-powered tools in diagnosing and assessing colorectal polyps. The study, which surveyed 165 doctors in the Asia-Pacific region, also found that more experienced gastroenterologists perceived a lower risk of AI tools.
A meta-analysis of 15 randomized studies found that patients taking GLP-1 medications experienced only mild differences in gastric emptying, delaying solid food by about 36 minutes. The findings suggest it may be safe to continue these medications before surgery without a high risk of aspiration.
Research presented at Digestive Disease Week 2024 reveals the risks associated with weight-loss drugs and alpha-gal syndrome. Studies found that GLP-1 weight loss drugs may increase the risk of biliary disease and gastroparesis, while an alpha-gal syndrome diagnosis is linked to GI symptoms in females.
Studies reveal distinct differences in oral microbiomes of patients with gastric cancer, premalignant conditions, and healthy controls. Researchers also found a surge in colorectal cancer incidence among young patients under 45, while late-stage gallbladder cancer is on the rise in non-Hispanic Blacks.